![]() |
市場調查報告書
商品編碼
2061471
壓平機市場機會、成長要素、產業趨勢分析及2026-2035年預測。Tablet Press Machines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
預計到 2025 年,全球壓片壓平機市場價值將達到 15.2 億美元,年複合成長率為 5.3%,到 2035 年將達到 25.6 億美元。

市場擴張主要受製藥業的持續成長和口服固體製劑產量增加的推動。片劑因其價格實惠、服用方便、保存期限長等優點,仍是最廣泛使用的給藥方式之一。慢性病在全球範圍內的日益普遍,進一步促使製藥公司擴大片劑生產,增加了對高產能、高性能壓片設備的需求。此外,學名藥生產的擴張也顯著促進了設備的普及,尤其是在新興市場,這些市場致力於為龐大的患者群體提供經濟有效的藥物。契約製造組織(CMO)也透過投資能夠處理不同配方和批量大小的靈活多功能壓片系統,進一步推動了需求成長。這種轉變推動了對先進設備的需求,這些設備能夠滿足整個製藥價值鏈的大規模生產需求,同時確保產品品質的穩定性。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 上市時的市場規模 | 15.2億美元 |
| 預計金額 | 25.6億美元 |
| 複合年成長率 | 5.3% |
預計2025年,多工位壓片機市場規模將達到10.8億美元。這類壓片機通常被稱為旋轉式壓片機,仍然是高產量生產環境的最佳選擇。這些機器採用具有多個工位的旋轉轉盤,可在每個循環中同時進行片劑壓制。與單工位系統相比,這種設計顯著提高了生產效率,使其成為對高產量要求極高的大規模製藥和營養補充劑生產企業的理想之選。
2025年,全自動片劑生產系統將佔據48%的市場。隨著全自動系統能夠以最小的人工干預實現片劑生產全過程的自動化,該細分市場正持續成長。粉末進料、壓片、重量調節和片劑排放等功能完全同步,確保產品品質穩定,並提高營運效率。此類系統廣泛應用於對精度、法規遵循和大規模生產要求極高的製藥和保健品生產企業。
美國壓片壓平機市場佔75.8%的佔有率,預計2025年市場規模將達到3.6億美元。該國市場成長的驅動力包括強勁的藥品需求、完善的醫療基礎設施和先進的生產能力。生產主要集中在用於治療慢性病和長期疾病的高品質口服固體製劑。此外,美國食品藥物管理局(FDA)實施的嚴格監管標準促使製造商投資先進的壓片技術,以確保整個生產週期內的合規性、精確性和產品一致性。
The Global Tablet Press Machines Market was valued at USD 1.52 billion in 2025 and is estimated to grow at a CAGR of 5.3% to reach USD 2.56 billion by 2035.

Market expansion is driven by the continuous growth of the pharmaceutical sector and the rising production of oral solid dosage drugs. Tablets remain one of the most widely used drug delivery formats due to their affordability, ease of administration, and extended shelf life. Increasing global prevalence of chronic diseases is further pushing pharmaceutical companies to scale up tablet production, thereby increasing demand for high-capacity and high-performance compression equipment. In addition, the expansion of generic drug manufacturing is contributing significantly to equipment adoption, particularly in emerging economies focused on delivering cost-effective medicines to large patient populations. Contract manufacturing organizations are also strengthening demand by investing in flexible and multi-functional tablet compression systems capable of handling varied formulations and batch sizes. This shift is reinforcing the need for advanced machinery that ensures consistent output quality while supporting large-scale production requirements across the pharmaceutical value chain.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $1.52 Billion |
| Forecast Value | $2.56 Billion |
| CAGR | 5.3% |
The multiple station machines segment generated USD 1.08 billion in 2025. This category, commonly known as rotary tablet presses, remains the preferred choice for high-volume production environments. These machines operate using a rotating turret equipped with multiple tooling stations that allow simultaneous tablet compression during each cycle. This design significantly enhances production efficiency compared to single-station systems, making them ideal for large-scale pharmaceutical and nutraceutical manufacturing operations where high throughput is essential.
The fully-automatic segment accounted for 48% share in 2025. This segment continues to expand due to its ability to automate the entire tablet production process with minimal human intervention. Functions such as powder feeding, compression, weight adjustment, and tablet ejection are fully synchronized, ensuring consistent product quality and improved operational efficiency. Such systems are widely adopted in pharmaceutical and nutraceutical production environments where precision, regulatory compliance, and large-scale output are critical requirements.
U.S. Tablet Press Machines Market held a 75.8% share, generating USD 0.36 billion in 2025. Market growth in the country is supported by strong pharmaceutical demand, a well-established healthcare infrastructure, and advanced manufacturing capabilities. Production is largely focused on high-quality oral solid dosage forms used in the treatment of chronic and long-term conditions. In addition, strict regulatory standards enforced by the FDA are encouraging manufacturers to invest in advanced tablet compression technologies that ensure compliance, precision, and product consistency across production cycles.
Major players operating in the Global Tablet Press Machines Industry include Fette Compacting, IMA Active, GEA Group, Korsch AG, Romaco, ACG Pharma Technologies, Manesty (Bosch/Syntegon), Sejong Pharmatech, Cadmach Machinery, Elizabeth Hata, Stokes, Shanghai Tianhe, Riddhi Pharma, Riva S.A., Glatt, PTK-GB, Fluid Pack, Karnavati/Rimek, Prism Pharma, Chamunda Pharma, and Compression Components & Service. Companies in the tablet press machines market are focusing on advancing automation and precision engineering to improve production efficiency and product consistency. Manufacturers are integrating digital monitoring systems, real-time process control, and predictive maintenance capabilities to reduce downtime and enhance operational reliability. Expansion of modular machine designs is enabling flexible production setups that accommodate different tablet sizes and formulations. Firms are also investing in high-speed rotary systems to meet growing demand for large-scale pharmaceutical manufacturing. Strategic partnerships with pharmaceutical companies and contract manufacturers are strengthening market penetration. Additionally, emphasis on regulatory compliance, energy-efficient systems, and reduced material wastage is helping companies improve competitiveness.